Ligand Pharmaceuticals LGND
NASDAQ LGND
$302.74 -9.63 (-3.08%)
At close: Oct 1, 2026 · 4:00 PM EDT

Ligand Pharmaceuticals (LGND) Cash from Operations (2010 - 2026)

Updated

Ligand Pharmaceuticals' Cash from Operations was $24.02 million in Q2 2026, up 52.0% from $15.8 million a year earlier but down 50.7% from the prior quarter.

Analysis

Ligand Pharmaceuticals (LGND) Cash from Operations (2010 - 2026) Analysis & Trends

On a trailing twelve-month basis, Ligand Pharmaceuticals' Cash from Operations was $131.71 million through Jun 30, 2026, up 137.9% year-over-year; for FY2025, it was $49.36 million, down 49.1% from FY2024.

  • Cash from Operations shows a five-year compound annual growth rate of -2.0% (FY2020 to FY2025).
  • In earlier years, Cash from Operations was $97.05 million in FY2024 (+95.8%), $49.58 million in FY2023 (-64.0%), $137.85 million in FY2022 (+74.9%) and $78.8 million in FY2021 (+44.4%).
  • Quarterly Cash from Operations has moved between -$25.45 million (Q1 2025) and $53.47 million (Q4 2022) over five years.
  • Compared with a year earlier, Cash from Operations was higher in five of the last six quarters, with growth averaging 116.4%.
  • The best year-over-year quarter for Cash from Operations over five years was Q1 2022 (growth of 383.6%); the worst was Q4 2023 (a decline of 84.9%).
  • Per Business Quant data, LGND's Cash from Operations in the three quarters before Q2 2026 was $48.69 million (Q1 2026), $45.92 million (Q4 2025) and $13.09 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 8.62 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 3.44 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 5.37 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 5.88 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 4.58 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 4.00 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 3.57 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 835.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 1.13 Bn
10 Ligand Pharmaceuticals 6.22 Bn 2.69 Bn - 24.02 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 24.02 Mn
Mar 31, 2026 48.69 Mn
Dec 31, 2025 45.92 Mn
Sep 30, 2025 13.09 Mn
Jun 30, 2025 15.80 Mn
Mar 31, 2025 -25.45 Mn
Dec 31, 2024 28.47 Mn
Sep 30, 2024 36.53 Mn
Jun 30, 2024 13.31 Mn
Mar 31, 2024 18.73 Mn
Dec 31, 2023 8.07 Mn
Sep 30, 2023 7.65 Mn
Jun 30, 2023 -82,000.00
Mar 31, 2023 33.95 Mn
Dec 31, 2022 53.47 Mn
Sep 30, 2022 20.49 Mn
Jun 30, 2022 11.88 Mn
Mar 31, 2022 52.01 Mn
Dec 31, 2021 27.64 Mn
Sep 30, 2021 20.03 Mn
API Access

Ligand Pharmaceuticals Cash from Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-operations&ticker=LGND&period=max&api_key=YOUR_API_KEY